Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-23

Clinical Trial Update: Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating tacrolimus plus glucocorticoid for severe thrombocytopenia in Sjogren syndrome with other organ involvement is ongoing, with status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucocorticoid (glucocorticoid)
  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Sjogren Syndrome With Other Organ Involvement | Phase 2, Phase 3 | Status: UNKNOWN